These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Role of cytokine-matrix metalloproteinase axis on promoting vascular neointima hyperplasia in mice]. Liu Y; Ning WH; Shen XH; Guo DL; Guo L Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):961-967. PubMed ID: 27903395 [No Abstract] [Full Text] [Related]
5. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694 [TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid inhibits intimal hyperplasia, vascular smooth muscle cell excessive proliferation, migration via blocking miR-21/PTEN/AKT/mTOR signaling pathway. Huang R; Huang Y; Zeng G; Li M; Jin Y Cell Cycle; 2020 Apr; 19(8):918-932. PubMed ID: 32202193 [TBL] [Abstract][Full Text] [Related]
7. Circular RNA CircMAP3K5 Acts as a MicroRNA-22-3p Sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated Smooth Muscle Cell Differentiation. Zeng Z; Xia L; Fan S; Zheng J; Qin J; Fan X; Liu Y; Tao J; Liu Y; Li K; Ling Z; Bu Y; Martin KA; Hwa J; Liu R; Tang WH Circulation; 2021 Jan; 143(4):354-371. PubMed ID: 33207953 [TBL] [Abstract][Full Text] [Related]
8. MTMR7 suppresses the phenotypic switching of vascular smooth muscle cell and vascular intimal hyperplasia after injury via regulating p62/mTORC1-mediated glucose metabolism. Sun X; Yang Y; Zhao W; Wang M; Chen Y; Wang J; Yang D; Yang Y Atherosclerosis; 2024 Mar; 390():117470. PubMed ID: 38342025 [TBL] [Abstract][Full Text] [Related]
9. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway. Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859 [TBL] [Abstract][Full Text] [Related]
10. A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia. Serrano RL; Yu W; Graham RM; Bryan RL; Terkeltaub R PLoS One; 2019; 14(4):e0212235. PubMed ID: 30943188 [TBL] [Abstract][Full Text] [Related]
12. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Wang L; Zheng J; Bai X; Liu B; Liu CJ; Xu Q; Zhu Y; Wang N; Kong W; Wang X Circ Res; 2009 Mar; 104(5):688-98. PubMed ID: 19168437 [TBL] [Abstract][Full Text] [Related]
13. Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROS/NFκB/MMP-9 Pathway. Sun HJ; Zhao MX; Ren XS; Liu TY; Chen Q; Li YH; Kang YM; Wang JJ; Zhu GQ Antioxid Redox Signal; 2016 Jun; 24(18):1045-57. PubMed ID: 26952533 [TBL] [Abstract][Full Text] [Related]
14. Small nucleolar RNA host gene 18 controls vascular smooth muscle cell contractile phenotype and neointimal hyperplasia. Niu K; Zhang C; Yang M; Maguire EM; Shi Z; Sun S; Wu J; Liu C; An W; Wang X; Gao S; Ge S; Xiao Q Cardiovasc Res; 2024 May; 120(7):796-810. PubMed ID: 38498586 [TBL] [Abstract][Full Text] [Related]
15. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury. Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088 [TBL] [Abstract][Full Text] [Related]
17. Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo. Schwaiberger AV; Heiss EH; Cabaravdic M; Oberan T; Zaujec J; Schachner D; Uhrin P; Atanasov AG; Breuss JM; Binder BR; Dirsch VM Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2475-81. PubMed ID: 20847306 [TBL] [Abstract][Full Text] [Related]
18. SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes. Qi W; Li Q; Liew CW; Rask-Madsen C; Lockhart SM; Rasmussen LM; Xia Y; Wang X; Khamaisi M; Croce K; King GL Diabetologia; 2017 Mar; 60(3):585-596. PubMed ID: 27933336 [TBL] [Abstract][Full Text] [Related]
19. Role of polypyrimidine tract-binding protein 1/yin yang 2 signaling in regulating vascular smooth muscle cell proliferation and neointima hyperplasia. Wang Z; Gan X; Qiu C; Yang D; Sun X; Zeng Z Toxicol Appl Pharmacol; 2019 Nov; 383():114747. PubMed ID: 31499192 [TBL] [Abstract][Full Text] [Related]
20. OCT4 regulated neointimal formation in injured mouse arteries by matrix metalloproteinase 2-mediated smooth muscle cells proliferation and migration. Ding X; Yan Y; Zhang C; Xu X; Yang F; Liu Y; Wang G; Qin Y J Cell Physiol; 2021 Jul; 236(7):5421-5431. PubMed ID: 33372301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]